3',4',7-Trihydroxyflavone Downregulates NO Production in LPS- or IFN-γ-Activated MG6 Microglial Cells by Attenuating

Tatsuhiro Akaishi1, Shohei Yamamoto1, Kazuho Abe1

  • 1Laboratory of Pharmacology, Faculty of Pharmacy and Research Institute of Pharmaceutical Sciences, Musashino University.

Insights

3

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Microglial activation drives neuroinflammation in neurodegenerative diseases like Alzheimer's.
  • 3',4',7-trihydroxyflavone shows neuroprotective potential against oxidative stress and amyloid-beta aggregation.
  • Its impact on microglial activation remains largely unexplored.

Purpose of the Study:

  • To investigate the anti-neuroinflammatory effects of 3',4',7-trihydroxyflavone on activated microglia.
  • To elucidate the underlying molecular mechanisms, focusing on signaling pathways.

Main Methods:

  • MG6 microglial cells were stimulated with lipopolysaccharide (LPS) or interferon-gamma (IFN-γ).
  • The effects of 3',4',7-trihydroxyflavone on nitric oxide (NO) generation, inducible NO synthase (iNOS) expression, and key signaling pathways (JNK, STAT1) were assessed.
  • Pharmacological inhibition of the JNK pathway was used for validation.

Main Results:

  • 3',4',7-trihydroxyflavone significantly inhibited LPS/IFN-γ-induced NO generation and iNOS upregulation.
  • It suppressed the phosphorylation of signal transducer and activator of transcription 1 (STAT1).
  • The compound specifically inhibited LPS-induced c-Jun N-terminal kinase (JNK) phosphorylation, but not ERK or p38 MAPK. Inhibition of JNK mimicked the anti-inflammatory effects.

Conclusions:

  • 3',4',7-trihydroxyflavone demonstrates significant anti-neuroinflammatory properties in microglia.
  • Its mechanism involves the inhibition of the JNK-STAT1 signaling pathway.
  • This flavonoid represents a potential therapeutic agent for neuroinflammatory conditions.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K